Sigridur K. Bodvarsdottir
Reykjavik, Iceland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.
Journal: Breast cancer research : BCR
Published: March 13, 2026
Mechanistic Insights into Tumorigenesis from Serum Proteins.
Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2025
Optimization of bottom-up proteomic sample preparation by design of experiments for absolute quantification of 257 proteins in human plasma using UPLC-MRM-MS.
Journal: Expert review of proteomics
Published: May 21, 2025
A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription.
Journal: Nature communications
Published: April 29, 2025
The effect of sample age on the metabolic information extracted from formalin-fixed and paraffin embedded tissue samples using desorption electrospray ionization mass spectrometry imaging.
Journal: Journal of mass spectrometry and advances in the clinical lab
Published: December 23, 2021
Lipidomic study of cell lines reveals differences between breast cancer subtypes.
Journal: PloS one
Published: December 16, 2019
Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: November 17, 2016
Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers.
Journal: The journal of pathology. Clinical research
Published: August 15, 2014
Dysfunctional telomeres in human BRCA2 mutated breast tumors and cell lines.
Journal: Mutation research
Published: April 26, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026